Barclays Initiates Coverage On Lumexa Imaging Holdings with Overweight Rating, Announces Price Target of $23
Benzinga Newsdesk 10 months ago
NewsPrice TargetInitiationAnalyst Ratings
Barclays initiates coverage on Lumexa Imaging Holdings (NASDAQ:LMRI) with a Overweight rating and announces Price Target of $23.
Barclays initiates coverage on Lumexa Imaging Holdings (NASDAQ:LMRI) with a Overweight rating and announces Price Target of $23.